| Mitsubishi Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Lenzburg - Radicava, Suspension zum Einnehmen | | 68016 | | 01 | | Radicava | | Suspension zum Einnehmen | | N07XX14 | | Edaravone | | 01.05.2023 | | |
| | Composition | | edaravonum 105 mg, poly(alcohol vinylicus), xanthani gummi, E 222 5 mg, cysteini hydrochloridum monohydricum, natrii hydroxidum q.s. ad pH, acidum phosphoricum q.s. ad pH, sorbitolum 2000 mg, simeticoni emulsio, aqua purificata, q.s. ad suspensionem pro 5 ml, natrium 1.10 mg. | | Packungsbestandteile | | Suspension (oral) | | | | | | Active Agent | Dose |
|---|
| Edaravonum | 105 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Cystein Hydrochloride Monohydrate | | | | E 222 | 5 mg | conserv. | | Sodium Hydroxide | | | | Poly(Alcohol Vinylicus) | | | | Xanthani Gummi | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 50 ml | PR | PR | B | | No | | 002 | 2 x 35 ml | PR | PR | B | | No |
|
|
